Publication | Closed Access

Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells

Aptamer-targeted DeliveryNovel TherapyPolymer-drug ConjugateMedicinePamam DendrimersBcl-xl ShrnaTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyLung CancerTumor BiologyBiomolecular Engineering